Ferrous gluconate, an iron(II) salt of gluconic acid (CAS 299-29-6), represents a critical component in global healthcare and nutrition markets, serving as a primary treatment for iron deficiency anemia and a key ingredient in food fortification programs worldwide. As a hematological drug with high bioavailability and excellent water solubility, ferrous gluconate has become increasingly essential in addressing global nutritional deficiencies affecting over 1.6 billion people . The global ferrous gluconate market is projected to grow from $786.3 billion in 2025 to $1,253.2 billion by 2035, demonstrating a solid 6.0% compound annual growth rate (CAGR)​ . This comprehensive analysis provides detailed insights into the global buyers landscape, covering pharmaceutical companies, food…